is_manufactured_by has role vaccinated in route immunizes against disease immunizes recipient immunizes against pathogen Lyme disease Borreliella burgdorferi Homo sapiens recombinant vaccine vector role intramuscular route licensed vaccine role Lymerix vaccine https://wayback.archive-it.org/7993/20170405164754/https://www.fda.gov/ohrms/dockets/ac/01/briefing/3680b2_03.pdf LYMErix [Lyme Disease Vaccine (Recombinant OspA)] is a noninfectious recombinant vaccine developed and manufactured by SmithKline Beecham Biologicals. The vaccine contains lipoprotein OspA, an outer surface protein of Borrelia burgdorferi sensu stricto ZS7, as expressed by Escherichia coli. Lipoprotein OspA is a single polypeptide chain of 257 amino acids with lipids covalently bonded to the N terminus. lipoprotein outer surface a vaccine https://www.rxlist.com/lymerix-drug.htm vaccine Discontinued in 2002 Oliver He Kallan Roan Lymerix Borrelia burgdorferi OspA protein vaccine licensed human Lyme disease vaccine GlaxoSmithKline plc